(HealthDay News) — For the five leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.

Investigators used the SEER-Medicare claims linked database to explore the persistence of racial-ethnic disparities in pain treatment among survivors of cancer.

The NCCN’s updated guidelines for the treatment of breast cancer include updates on sentinel lymph node biopsy, ovarian function suppression, and the use of prognostic tools.

Ensemble integrating three architectures achieved area under the curve of 0.9208, outperforming individual models ...

(HealthDay News) — Federal officials have lifted a short pause on more than 100 public health grants worth over $5 billion, allowing states to continue work aimed at strengthening health systems.

In this analysis, the researchers used data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial to examine the link between alcohol intake and colorectal cancer.

To evaluate the clinical benefit of extended endocrine therapy after 5 years of adjuvant treatment with LHRHa in premenopausal women with node-positive, HR-positive early breast cancer.

(HealthDay News) — The United States has officially pulled out of the World Health Organization (WHO), a year after President Donald Trump announced plans to leave the global health group.

In this global network study, researchers examined vitamin B12 levels as a possible biomarker for outcomes in colon cancer.

Investigators compared the efficacy and safety of suvemcitug plus chemotherapy vs chemotherapy plus placebo for patients with platinum-refractory or resistant ovarian cancer.

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian cancer in a phase 3 study.